• Epilepsy and cannabidiol: a guide to treatment 

      Arizmanoglou, Alexis; Brandl, Ulrich; Cross, Helen; Gil-nagel, Antonio; Lagae, Lieven; Landmark, Cecilie Johannessen; Specchio, Nicola; Nabbout, Rima; Thiele, Elisabeth; Gubbay, Oliver (Epileptic Disorders;Volume 22, Issue 1, February 2020, Journal article; Peer reviewed, 2020-12-19)
      The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment for epilepsy, among other conditions, is reflected in recent changes in legislation in some countries. Although there has been much ...
    • Pharmacology and drug interactions of cannabinoids 

      Landmark, Cecilie Johannessen; Ulrich, Brandl (Epileptic Disorders;Vol. 22, Supplement 1, Journal article; Peer reviewed, 2020)
      Cannabinoids include a variety of substances, of which cannabidiol (CBD) is the main substance investigated for the treatment of epilepsy, and this will be the focus in the present review. CBD preparations exist in various ...
    • The role of new medical treatments for the management of developmental and epileptic encephalopathies: Novel concepts and results 

      Landmark, Cecilie Johannessen; Potschka, Heidrun; Auvin, Stephane; Wilmhurst, Jo M.; Johannessen, Svein; Trenite, Dorothee K. N.; Wirrell, Elaine (Epilepsia;volume 62, issue 4, Peer reviewed; Journal article, 2021-02-27)
      Developmental and epileptic encephalopathies (DEEs) are among the most chal- lenging of all epilepsies to manage, given the exceedingly frequent and often severe seizure types, pharmacoresistance to conventional antiseizure ...